Foundation for innovation
in Cardiometabolism and Nutrition

CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC network

American Journal of Hematology

CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC network

Publié le 

Restez en contact

Recevez toute l’actualité de la fondation ICAN

This field is for validation purposes and should be left unchanged.

Nos fondateurs

CERTIFIÉ ISO 9001

Nos soutiens institutionnels

Notre réseau